Source: International Congress 2016 – Lung cancer immunology: latest research
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Joanna Domagała-Kulawik (Warsaw, Poland), Joanna Domagala-Kulawik, Iwona Osinska, Dominika Wolosz, Monika Pasieka-Lis, Juliusz Pankowski. Regulatory vs. cytotoxic cells in lymph nodes of lung cancer patients resected by TEMLA. Eur Respir J 2016; 48: Suppl. 60, 1772

Member's Comments

No comment yet.

Related content which might interest you: Mediastinal lymph nodes (MLN) vascular pattern utilitiy to predict progression in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients? Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Myeloid antigen presenting cells in lung adenocarcinoma lymph nodes assessed by endobronchial ultrasound Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 Analysis of FOXP3 expression in the lymph nodes of patients with lung adenocarcinoma- The pilot study Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC) Source: International Congress 2016 – EBUS and transthoracic ultrasound Year: 2016 The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Evaluation of lung cancer patients with distant organ metastasis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Profile of non-neoplasic mediastinal lymph nodes (NNLN) during the study of lung cáncer (LC) Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 EBUS-TBNA for nodal restaging and relapse in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Recombination of B7-H4 and CD68 predicted lymph node metastasis in human lung carcinoma Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 PET-CT predictors of mediastinal dissemination in lung cancer Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery Year: 2014 Functional impairment of NK cells in non-small-cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Distribution of CD4+Foxp3+,CD4+ and CD8+ T cells in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 The prognostic significance of metastasis to aortopulmonary lymph nodes in completely resected left lung tumors Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Survival of non small cell lung carcinoma patients with malignant pleural effusions Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014